期刊文献+

D-赖氨酸盐酸盐的制备研究 被引量:1

Preparation of D-lysine monohydrochloride from L-lysine monohydrochloride
原文传递
导出
摘要 目的:从L-赖氨酸盐酸盐制备D-赖氨酸盐酸盐。方法:经L-赖氨酸盐酸盐消旋制得的DL-赖氨酸,以L-酒石酸为手性拆分剂,生成D-赖氨酸-L-酒石酸盐,再经无机酸钙沉淀L-酒石酸,制得D-赖氨酸盐酸盐。结果:DL-赖氨酸与L-酒石酸反应适宜的摩尔比为1∶0.8,反应温度为60~70℃。碳酸钙、氢氧化钙和氧化钙分离D-赖氨酸的收率分别为34.6%,34.0%和33.9%,含量分别为85.7%,90.3%和90.6%。纯化后的D-赖氨酸盐酸盐产品,其含量和光学纯度均达99%以上。结论:用L-酒石酸拆分DL-赖氨酸是可行的,用无机酸钙分离D-赖氨酸与L-酒石酸是有效的。 Objective: To prepare D-lysine monohydrochloride from L-lysine monohydrochloride. Meth- ods: After racemization of L-lysine monohydrochloride, the obtained DL-lysine was resoluted to D-lysine-L-tartrate using L-tartaric acid as resolving agent; subsequently D-lysine monohydrochloride was separated from calcium tar- trate precipitation by inorganic acid calcium. Results : The optimum conditions of resolution reaction involved 1 : 0.8 molar ratio of DL-lysine to L-tartaric acid at 60 70 C reaction temperature. The yields of crude D-lysine from D- lysine-L-tartrate solution after precipitation using calcium carbonate, calcium hydroxide and calcium oxide were 34.6% , 34.0% and 33.9% with purities of 85.7% , 90.3% and 90.6% , respectively. Both the chemical purity and optical purity of the purified D-lysine monohydrochloride were above 99%. Conclusion: The resolution of DL- lysine using L-tartaric acid as resolving agent is teasible, and the separation of D-lysine from D-lysine-L-tartrate is effective with inorganic acid calcium.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第22期2698-2701,共4页 Chinese Journal of New Drugs
基金 江苏省"六大人才高峰"资助项目(2011-JY-012) 江苏省"青蓝工程"资助项目(苏教师[2010]27号)
关键词 DL-赖氨酸 D-赖氨酸盐酸盐 L-酒石酸 无机酸钙 DL-lysine D-lysine monohydrochloride L-tartaric acid inorganic acid calcium
  • 相关文献

参考文献9

  • 1BAJUSZ S,JANAKY T,CSERNUS VJ,et al.Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone[J].Proc Natl Acad Sci USA,1989,86(16):6313-6317.
  • 2SENSI M,PRICCI F,DE ROSSI MG,et al.D-Lysine effectively decreases the non-enzymic glycation of proteins in vitro[J].Clin Chem,1989,35(3):384-387.
  • 3VERWIJNEN SM,KRENNING EP,VALKEMA R,et al.Oral versus intravenous administration of lysine:equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide[J].J Nucl Med,2005,46(12):2057-2060.
  • 4KAMINSKI HM,FEIX JB.Effects of D-lysine substitutions on the activity and selectivity of antimicrobial peptide CM15[J].Polymers,2011,3(4):2088-2106.
  • 5BENFENATI V,TOFFANIN S,CAPELLI R,et al.A silk platform that enables electrophysiology and targeted drug delivery in brain astroglial cells[J].Biomaterials,2010,31(31):7883-7891.
  • 6刘毅,焦庆才,印晓星.化学生物耦合法制备D-赖氨酸[J].现代化工,2007,27(5):32-34. 被引量:4
  • 7廖晓垣.D-赖氨酸盐酸盐的研制[J].氨基酸和生物资源,1999,21(3):30-31. 被引量:5
  • 8TAKAHASHI E,FURUI M,SEKO H,et al.D-Lysine production from L-lysine by successive chemical racemization and microbial asymmetric degradation[J].Appl Microbiol Biotechnol,1997,47(4):347-351.
  • 9陈文婕,江立新,张瑾,等.一种DL-赖氨酸的制备方法:中国,101624351A[P].2010-01-13.

二级参考文献12

  • 1刘毅,郭丽芸,吴晓燕,焦庆才.微波辐射下L-氨基酸的快速消旋方法[J].化学通报,2005,68(12):935-938. 被引量:5
  • 2孙志强.2005年蛋氨酸市场回顾与2006年展望[J].饲料博览,2006(3):34-36. 被引量:1
  • 3化学工业出版社.中国化工产品大全(第二版)[M].北京:化学工业出版社,1998..
  • 4黄宜基(译).-[J].氨基酸杂志(氨基酸和生物资源),1984,(4):60-60.
  • 5曹稳根.-[J].氨基酸和生物资源,1995,17(2):47-47.
  • 6Bajusz S,Janaky T,Csemus J,et al.Highly potent metallopetide analogs of luteinizing hormone-releasing hormone[J].Proc Nail Acad Sci USA,1989,86(16):6313—6317.
  • 7Shen W C,Du X,Feener E P,et al.The intracellular release of methotrexate from a synthetic drug carrier system targeted to Fcreceptorbearing cells[J].J Controlled Release,1989,10:89—96.
  • 8中国化工产品大全[M].2版.北京:化学工业出版社,1998.
  • 9Yamada S,Hongo C,Yoshioka R,et al.Method for the racemization of optically active amino acid[J].J Org Chem,1983,48(6):843—846.
  • 10Ebbers E J,Ariaans G J A,Houbiers J P M,et al.Controlled racemization of optically active organic compounds:Prospects for asymmetric transformation[J].Tetrahedron,1997,53(28):9417—9476.

共引文献7

同被引文献21

  • 1蒋丽丽,吴晓燕,刘毅,刘茜,焦庆才.赖氨酸脱羧酶发酵工艺及酶学性质[J].精细化工,2006,23(11):1060-1063. 被引量:12
  • 2刘毅,焦庆才,印晓星.化学生物耦合法制备D-赖氨酸[J].现代化工,2007,27(5):32-34. 被引量:4
  • 3萨姆布鲁克J 拉塞尔DW著 黄培堂 译.分子克隆实验指南[M].北京:科学出版社,2002.481-482.
  • 4Takahashi E,Furui M,Shibatani T.D-lysine production from L-lysine by successive chemical racemization and microbial asymmetric degradation[J].Appl Microbiol Biot,1997,47(4):347-351.
  • 5Friedman M,Levin C E.Nutritional and medicinal aspects of Damino acids[J].Amino Acids,2012,42(5):1553-1582.
  • 6Stabler N,Oikawa T,Bott M,et al.Corynebacterium glutamicum as a host for synthesis and export of D-amino acids[J].J Bacteriol,2011,193(7):1702-1709.
  • 7Kaminski Heather M,Feix Jimmy B.Effects of D-Lysine substitutions on the activity and selectivity of antimicrobial peptide CM15[J].Polymers,2011,3(4):2088-2106.
  • 8Sato H,Feix J B.Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity[J].Antimicrob Agents CH,2008,52(12):4463-4465.
  • 9Verwijnen S J,Krenning E P,Valkema R,et al.Oral versus intravenous administration of lysine:Equal effectiveness in reduction of renal uptake of[In-111-DTPA]octreotide[J].J Nucl Med,2005,46(12):2057-2060.
  • 10Boyd B J,Kaminsjas P,Krippner G,et al.Cationic poly-L-lysine dendrimers:Pharmacokinetics,biodistribution,and evidence for metabolism and bioresorption after intravenous administration to rats[J].Mol Pharmacol,2006,3(5):614-627.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部